Age differences in the use of implantable cardioverter-defibrillators among older patients hospitalized with heart failure

Journal of Cardiovascular Electrophysiology

Volumn 24, Issue 6, 2013, Pages 664-671

  Hess, Paul L ^a,b   Grau Sepulveda, Maria V ^a   Hernandez, Adrian F ^a,b   Peterson, Eric D ^a,b   Bhatt, Deepak L ^c,d,e   Schwamm, Lee H ^d,f   Yancy, Clyde W ^g   Fonarow, Gregg C ^h   Al Khatib, Sana M ^a,b  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Veterans Affairs Boston Health System   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g NORTHWESTERN UNIVERSITY   (United States)

^h UCLA MEDICAL CENTER   (United States)

Author keywords

age; defibrillator; healthcare disparities; heart failure; implantable; sex

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL;

AGE FACTORS; AGED; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED;

EID: 84878574765     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12100     Document Type: Article

References (31)

1. Myerburg RJ, Kessler KM, Castellanos A,: Sudden cardiac death: Epidemiology, transient risk, and intervention assessment. Ann Intern Med 1993; 119: 1187-1197.
2. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G,; Multicenter Unsustained Tachycardia Trial investigators: A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999; 341: 1882-1890.
3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML,: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883.
4. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH,: Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004; 350: 2151-2158.
5. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH,: Amiodarone or implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.
6. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW,: ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am College Cardiol 2005; 46: e1-e82.
7. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Blanc JJ, Budaj A, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL,: ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association task force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006; 48: e247-e346.
8. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Riegel B, Tarkington LG, Yancy CW,: ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008; 117: e350-e408.
9. Hernandez AF, Fonarow GC, Liang L, Al-Khatib SM, Curtis LH, LaBresh KA, Yancy C, Albert NM, Peterson ED,: Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA 2007; 298: 1525-1532.
10. Al-Khatib SM, Hellkamp AS, Hernandez AF, Fonarow GC, Thomas KL, Al-Khalidi HR, Heidenreich PA, Hammill BG, Yancy C, Peterson ED,: Trends in use of implantable cardioverter defibrillator therapy among patients hospitalized for heart failure: Have the previously observed sex and racial disparities changed over time? Circulation 2012: 1094-1101.
11. Fonarow GC, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN,: Heart failure care in the outpatient cardiology practice setting: Findings from IMPROVE HF. Circ Heart Fail 2008; 1: 98-106.
12. Forman DE, Cannon CP, Hernandez AF, Liang L, Yancy C, Fonarow GC,: Influence of age on the management of heart failure: Findings from Get With The Guidelines-Heart Failure (GWTG-HF). Am Heart J 2009; 157: 1010-1017.
13. Yancy CW, Fonarow GC, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN,: Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: Findings from IMPROVE HF. Am Heart J 2009; 157: 754-762 e752.
14. Federal Interagency Forum on Aging-Related Statistics. Older Americans 2010: Key indicators of well-being 2010; 1-56.
15. Kong MH, Al-Khatib SM, Sanders GD, Hasselblad V, Peterson ED,: Use of implantable cardioverter-defibrillators for primary prevention in older patients: A systematic literature review and meta-analysis. Cardiol J 2011; 18: 503-514.
16. Redberg RF,: Disparities in use of implantable cardioverter- defibrillators: Moving beyond process measures to outcomes data. JAMA 2007; 298: 1564-1566.
17. Hernandez AF, Fonarow GC, Hammill BG, Al-Khatib SM, Yancy CW, O'Connor CM, Schulman KA, Peterson ED, Curtis LH,: Clinical effectiveness of implantable cardioverter-defibrillators among medicare beneficiaries with heart failure. Circ Heart Fail 2010; 3: 7-13.
18. Swindle JP, Rich MW, McCann P, Burroughs TE, Hauptman PJ,: Implantable cardiac device procedures in older patients: Use and in-hospital outcomes. Arch Intern Med 2010; 170: 631-637.
19. Tsai V, Goldstein MK, Hsia HH, Wang Y, Curtis J, Heidenreich PA,: Influence of age on perioperative complications among patients undergoing implantable cardioverter-defibrillators for primary prevention in the United States. Circ Cardiovasc Qual Outcomes 2011; 4: 549-556.
20. Sanders GD, Kong MH, Al-Khatib SM, Peterson ED,: Cost-effectiveness of implantable cardioverter defibrillators in patients >or = 65 years of age. Am Heart J 2010; 160: 122-131.
21. Chan PS, Nallamothu BK, Spertus JA, Masoudi FA, Bartone C, Kereiakes DJ, Chow T,: Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention. Circ Cardiovasc Qual Outcomes 2009; 2: 16-24.
22. Groeneveld PW, Farmer SA, Suh JJ, Matta MA, Yang F,: Outcomes and costs of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death among the elderly. Heart Rhythm 2008; 5: 646-653.
23. Huang DT, Sesselberg HW, McNitt S, Noyes K, Andrews ML, Hall WJ, Dick A, Daubert JP, Zareba W, Moss AJ,: Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: A MADIT-II substudy. J Cardiovasc Electrophysiol 2007; 18: 833-838.
24. Friedmann E, Thomas SA, Inguito P, Kao CW, Metcalf M, Kelley FJ, Gottlieb SS,: Quality of life and psychological status of patients with implantable cardioverter defibrillators. J Interv Card Electrophysiol 2006; 17: 65-72.
25. Afilalo J, Karunananthan S, Eisenberg MJ, Alexander KP, Bergman H,: Role of frailty in patients with cardiovascular disease. Am J Cardiol 2009; 103: 1616-1621.
26. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA,: Frailty in older adults: Evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56: M146-M156.
27. Forman DE, Rich MW, Alexander KP, Zieman S, Maurer MS, Najjar SS, Cleveland JC Jr, Krumholz HM, Wenger NK,: Cardiac care for older adults. Time for a new paradigm. J Am Coll Cardiol 2011; 57: 1801-1810.
28. Goldstein NE, Lampert R, Bradley E, Lynn J, Krumholz HM,: Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med 2004; 141: 835-838.
29. Ghanbari H, Dalloul G, Hasan R, Daccarett M, Saba S, David S, Machado C,: Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: A meta-analysis of randomized controlled trials. Arch Intern Med 2009; 169: 1500-1506.
30. LaPointe NM, Al-Khatib SM, Piccini JP, Atwater BD, Honeycutt E, Thomas K, Shah BR, Zimmer LO, Sanders G, Peterson ED,: Extent of and reasons for nonuse of implantable cardioverter defibrillator devices in clinical practice among eligible patients with left ventricular systolic dysfunction. Circ Cardiovasc Qual Outcomes 2011; 4: 146-151.
31. Allen LA, Hernandez AF, Peterson ED, Curtis LH, Dai D, Masoudi FA, Bhatt DL, Heidenreich PA, Fonarow GC,: Discharge to a skilled nursing facility and subsequent clinical outcomes among older patients hospitalized for heart failure. Circ Heart Fail 2011; 4: 293-300.